Cargando…
The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico
BACKGROUND: Dengue is an important arboviral disease with about 100 million dengue cases per year, of which, ~5% result in severe disease. Clinical differentiation of dengue from other acute febrile illnesses (AFI) is difficult, and diagnostic blood tests are costly. We evaluated the utility of anti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988914/ https://www.ncbi.nlm.nih.gov/pubmed/31995560 http://dx.doi.org/10.1371/journal.pntd.0007971 |
_version_ | 1783492329215098880 |
---|---|
author | Caraballo, Elba Poole-Smith, B. Katherine Tomashek, Kay M. Torres-Velasquez, Brenda Alvarado, Luisa I. Lorenzi, Olga D. Ramos, Carmen Carrión, Jessica Hunsperger, Elizabeth |
author_facet | Caraballo, Elba Poole-Smith, B. Katherine Tomashek, Kay M. Torres-Velasquez, Brenda Alvarado, Luisa I. Lorenzi, Olga D. Ramos, Carmen Carrión, Jessica Hunsperger, Elizabeth |
author_sort | Caraballo, Elba |
collection | PubMed |
description | BACKGROUND: Dengue is an important arboviral disease with about 100 million dengue cases per year, of which, ~5% result in severe disease. Clinical differentiation of dengue from other acute febrile illnesses (AFI) is difficult, and diagnostic blood tests are costly. We evaluated the utility of anti-DENV IgM in urine to identify dengue cases among AFI patients enrolled in a clinical study. METHODS: Between May 2012-March 2013, 1538 study participants with fever for ≤7 days were enrolled, a medical history was obtained, and serum and urine specimens were collected. Serum was tested for DENV RNA and anti-DENV IgM. Urine was tested for anti-DENV IgM, and its sensitivity and specificity to detect sera laboratory-positive dengue cases were calculated. We evaluated if urine anti-DENV IgM positivity early (≤5 days post-illness onset [DPO]) and late (6–14 DPO) in the clinical course was associated with dengue severity. RESULTS: Urine anti-DENV IgM sensitivity and specificity were 47.4% and 98.5%, respectively, when compared with serum anti-DENV IgM ELISA results, and 29.7% and 91.1% when compared with serum rRT-PCR results. There was no correlation between urine anti-DENV IgM positivity and patient sex or pre-existing chronic disease. Early in the clinical course, a significantly higher proportion of those who developed dengue with warning signs had anti-DENV IgM in their urine when compared to those without warning signs (20.4% vs. 4.3%). There was no difference in the proportion with urine anti-DENV IgM positivity between severity groups late in the clinical course. CONCLUSION: While detection of urine anti-DENV IgM lacked adequate diagnostic sensitivity, it is a highly specific marker for laboratory-positive dengue, and its presence early in the clinical course may distinguish those with more severe disease. Further assessment of urine anti-DENV IgM by DPO is warranted to determine its utility as an early diagnostic (and possibly prognostic) marker for dengue. |
format | Online Article Text |
id | pubmed-6988914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-69889142020-02-20 The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico Caraballo, Elba Poole-Smith, B. Katherine Tomashek, Kay M. Torres-Velasquez, Brenda Alvarado, Luisa I. Lorenzi, Olga D. Ramos, Carmen Carrión, Jessica Hunsperger, Elizabeth PLoS Negl Trop Dis Research Article BACKGROUND: Dengue is an important arboviral disease with about 100 million dengue cases per year, of which, ~5% result in severe disease. Clinical differentiation of dengue from other acute febrile illnesses (AFI) is difficult, and diagnostic blood tests are costly. We evaluated the utility of anti-DENV IgM in urine to identify dengue cases among AFI patients enrolled in a clinical study. METHODS: Between May 2012-March 2013, 1538 study participants with fever for ≤7 days were enrolled, a medical history was obtained, and serum and urine specimens were collected. Serum was tested for DENV RNA and anti-DENV IgM. Urine was tested for anti-DENV IgM, and its sensitivity and specificity to detect sera laboratory-positive dengue cases were calculated. We evaluated if urine anti-DENV IgM positivity early (≤5 days post-illness onset [DPO]) and late (6–14 DPO) in the clinical course was associated with dengue severity. RESULTS: Urine anti-DENV IgM sensitivity and specificity were 47.4% and 98.5%, respectively, when compared with serum anti-DENV IgM ELISA results, and 29.7% and 91.1% when compared with serum rRT-PCR results. There was no correlation between urine anti-DENV IgM positivity and patient sex or pre-existing chronic disease. Early in the clinical course, a significantly higher proportion of those who developed dengue with warning signs had anti-DENV IgM in their urine when compared to those without warning signs (20.4% vs. 4.3%). There was no difference in the proportion with urine anti-DENV IgM positivity between severity groups late in the clinical course. CONCLUSION: While detection of urine anti-DENV IgM lacked adequate diagnostic sensitivity, it is a highly specific marker for laboratory-positive dengue, and its presence early in the clinical course may distinguish those with more severe disease. Further assessment of urine anti-DENV IgM by DPO is warranted to determine its utility as an early diagnostic (and possibly prognostic) marker for dengue. Public Library of Science 2020-01-29 /pmc/articles/PMC6988914/ /pubmed/31995560 http://dx.doi.org/10.1371/journal.pntd.0007971 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Caraballo, Elba Poole-Smith, B. Katherine Tomashek, Kay M. Torres-Velasquez, Brenda Alvarado, Luisa I. Lorenzi, Olga D. Ramos, Carmen Carrión, Jessica Hunsperger, Elizabeth The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico |
title | The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico |
title_full | The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico |
title_fullStr | The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico |
title_full_unstemmed | The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico |
title_short | The detection of anti-dengue virus IgM in urine in participants enrolled in an acute febrile illness study in Puerto Rico |
title_sort | detection of anti-dengue virus igm in urine in participants enrolled in an acute febrile illness study in puerto rico |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988914/ https://www.ncbi.nlm.nih.gov/pubmed/31995560 http://dx.doi.org/10.1371/journal.pntd.0007971 |
work_keys_str_mv | AT caraballoelba thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT poolesmithbkatherine thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT tomashekkaym thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT torresvelasquezbrenda thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT alvaradoluisai thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT lorenziolgad thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT ramoscarmen thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT carrionjessica thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT hunspergerelizabeth thedetectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT caraballoelba detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT poolesmithbkatherine detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT tomashekkaym detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT torresvelasquezbrenda detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT alvaradoluisai detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT lorenziolgad detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT ramoscarmen detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT carrionjessica detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico AT hunspergerelizabeth detectionofantidenguevirusigminurineinparticipantsenrolledinanacutefebrileillnessstudyinpuertorico |